FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068661 [Registered on: 11/06/2024] Trial Registered Prospectively
Last Modified On: 10/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To compare the usefulness between two different chest blocks for pain relief in patients posted for chest surgery 
Scientific Title of Study   Comparing erector spinae plane block and serratus anterior plane block for quality of recovery in patients posted for thoracotomy A prospective randomised double blinded controlled study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chandra Shekhar kumar 
Designation  Post graduate student 
Affiliation  Indira Gandhi Institute of Medical Sciences  
Address  Department of Anaesthesia neuro OT complex. 1st floor ward block,IGIMS,Sheikhpura, Patna,Bihar 800014 India

Patna
BIHAR
800014
India 
Phone  6201575759  
Fax    
Email  chandrashekhar613@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Chandra Shekhar kumar 
Designation  Post graduate student 
Affiliation  Indira Gandhi Institute of Medical Sciences  
Address  Department of Anaesthesia,Neuro OT complex,1ST floor ward block,IGIMS,Sheikhpura, Patna,Bihar 800014 India

Patna
BIHAR
800014
India 
Phone  6201575759  
Fax    
Email  chandrashekhar613@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR ALOK KUMAR BHARTI 
Designation  Associate professor 
Affiliation  Indira Gandhi Institute of Medical Sciences  
Address  Department of Anaesthesia,Neuro OT complex,1ST floor ward block,IGIMS,Sheikhpura, Patna,Bihar 800014 India

Patna
BIHAR
800014
India 
Phone  6392180381  
Fax    
Email  alok.bharti48@gmail.com  
 
Source of Monetary or Material Support  
Indira Gandhi Institute of Medical Sciences,Patna,Bihar,India, 800014 
 
Primary Sponsor  
Name  Dr Chandra Shekhar Kumar 
Address  Department of Anaesthesia,Neuro OT complex,1ST floor ward block,IGIMS,Sheikhpura, Patna,Bihar 800014 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Chandra shekhar kumar  Indira gandhi institute of medical sciences,patna  Department of Anaesthesia,Neuro OT complex,1ST floor ward block,IGIMS,Sheikhpura, Patna,Bihar 800014 India
Patna
BIHAR 
6201575759

chandrashekhar613@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES,PATNA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: J99||Respiratory disorders in diseasesclassified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Erector spinae plane block  Group ESP will receive 0.375% ropivacaine(0.5 ml/kg) with general anaesthesia to assess the quality of recovery(QOR) at 24 hours. 
Comparator Agent  Serratus anterior plane block  Group SAP will receive 0.375% ropivacaine(0.5ml/kg) with general anaesthesia to assess quality of recovery(QOR) at 24 hours. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients age between 18-70 years of either sex
Patients able to comprehend and willing to participate
ASA physical status l-lll
Patients scheduled to undergo for unilateral thoracotomy under general anaesthesia
 
 
ExclusionCriteria 
Details  Patients refusal to participate
Allergy to local anaesthetics
Chronic opioid use or history of chronic pain
Infection at block site
Cognitive dysfunction or psychiatric illness
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Primary outcome is to assess quality of recovery using QOR-15 scale at 24 hours postoperatively.  Postoperative 24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
To assess pain score using NRS scale upto 24 hours,time to rescue analgesia use,total analgesic consumption upto 24 hours,patients satisfaction and any adverse effects seen.  Pain score will be recorded at rest and during coughing using NRS scores at 0,3,6,12,18 and 24 hours. 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/07/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   A total of 120 thoracotomy patients have been equally divided into 2 groups(60 in each groups) receiving ESP and SAP blocks.Both group will receive 0.375% ropivacaine(0.5 ml/kg) with general anaesthesia.Patients included in our study are of age group between 18-70 years,ASA physical status 1-3,those willing to participate and able to comprehend.Patients excluded in our study are those allergic to local anaesthesia,chronic opioid use,infection at block site,cognitive dysfunction or psychiatric illness.We will compare ESP and SAP blocks and primary outcome will be to assess quality of recovery using QOR-15 scale at 24 hr postoperatively.and secondary outcome will be to assess post operative analgesia using NRS scale at 0,3,6,12,18 and 24 hours. 
Close